Biblio Discovery — Demo Discovery Service

4 hasil untuk "Febriyani Febriyani"

Menampilkan 1–4 · 0,32 detik · RSS

  1. Artikel Jurnal

    The Effect of Influencer Marketing, Social Media Engagement, and Product Knowledge on Brand Awareness in Tiktok Shop

    Sujoko Sujoko; Febriyani Febriyani; Agung Hartadi

    Danadyaksa, Vol. 4 No. 1 · 2026 · Indonesia · DOAJ

    This study aims to determine the effect of influencer marketing, social media engagement, and product knowledge on brand awareness in TikTok Shop. This study uses primary data with a data collection method through distributing questionnaires that have been tested for validity and reliability. The…

  2. Artikel Jurnal

    Kajian Pengetahuan, Sikap Dan Persepsi Pedagang Tentang Kualitas Kesehatan Lingkungan Pasar

    Ahmad Faizal Rangkuti; Musfirah Musfirah; Febriyani Febriyani

    Window of Health, Pp 227-239 (2020) · 2020 · Indonesia · DOAJ

    Indonesia merupakan salah satu negara berkembang yang memiliki masalah kesehatan lingkungan yang sangat kompleks terutama di kota-kota besar. Sanitasi yang buruk diyakini menjadi penyebab utama dalam 280.000 kematian. Pasar Giwangan sebagai tempat umum yang banyak dikunjungi banyak orang memiliki…

  3. Artikel Jurnal

    Tradition in modern islamic education and the hermeneutics of education in the perspective of Buya Hamka

    Febriyani Febriyani; Eman Suherman; Iqbal Hidayatsyah Noor dkk.

    Al-Misbah: Jurnal Islamic Studies, Vol. 12 No. 1 · 2024 · Indonesia · DOAJ

    This research uses a qualitative approach with the type of research is library research. The data source of this research uses primary data and secondary data. This research aims to find out the thoughts or hermeneutics of education from Buya Hamka's perspective. The results of this study provide…

  4. Artikel Jurnal

    Low-Dose Pazopanib in Metastatic Renal Cell Carcinoma: A Retrospective Survival Study

    Febriyani Febriyani; Rachmat Budi Santoso; Edward Usfie Harahap dkk.

    Indonesian Journal of Cancer, Vol. 20 No. 2 · 2026 · Inggris · DOAJ

    Background: Pazopanib is approved as a first-line targeted therapy for metastatic renal cell carcinoma (mRCC), typically initiated at 800 mg once daily. However, maintaining this standard dose is often challenging due to patients’ poor general condition and treatment-related adverse effects. Few…